These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 35543185)

  • 21. In Silico Prediction of Major Clearance Pathways of Drugs among 9 Routes with Two-Step Support Vector Machines.
    Wakayama N; Toshimoto K; Maeda K; Hotta S; Ishida T; Akiyama Y; Sugiyama Y
    Pharm Res; 2018 Aug; 35(10):197. PubMed ID: 30143865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction of Human Clearance Using In Silico Models with Reduced Bias.
    Lombardo F; Bentzien J; Berellini G; Muegge I
    Mol Pharm; 2024 Mar; 21(3):1192-1203. PubMed ID: 38285644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A rapid computational filter for predicting the rate of human renal clearance.
    Paine SW; Barton P; Bird J; Denton R; Menochet K; Smith A; Tomkinson NP; Chohan KK
    J Mol Graph Model; 2010 Dec; 29(4):529-37. PubMed ID: 21075652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In silico prediction of major drug clearance pathways by support vector machines with feature-selected descriptors.
    Toshimoto K; Wakayama N; Kusama M; Maeda K; Sugiyama Y; Akiyama Y
    Drug Metab Dispos; 2014 Nov; 42(11):1811-9. PubMed ID: 25128502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The contribution of the hydrogen bond acidity on the lipophilicity of drugs estimated from chromatographic measurements.
    Pallicer JM; Pascual R; Port A; Rosés M; Ràfols C; Bosch E
    Eur J Pharm Sci; 2013 Feb; 48(3):484-93. PubMed ID: 23262061
    [TBL] [Abstract][Full Text] [Related]  

  • 26. First-principle, structure-based prediction of hepatic metabolic clearance values in human.
    Li H; Sun J; Sui X; Liu J; Yan Z; Liu X; Sun Y; He Z
    Eur J Med Chem; 2009 Apr; 44(4):1600-6. PubMed ID: 18768239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A GFR-Based Method to Predict the Effect of Renal Impairment on the Exposure or Clearance of Renally Excreted Drugs: A Comparative Study Between a Simple GFR Method and a Physiologically Based Pharmacokinetic Model.
    Mahmood I
    Drugs R D; 2020 Dec; 20(4):377-387. PubMed ID: 33150526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In silico prediction of total human plasma clearance.
    Berellini G; Waters NJ; Lombardo F
    J Chem Inf Model; 2012 Aug; 52(8):2069-78. PubMed ID: 22715914
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Chen J; Yang H; Zhu L; Wu Z; Li W; Tang Y; Liu G
    Chem Res Toxicol; 2020 Feb; 33(2):640-650. PubMed ID: 31957435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravitreal clearance and volume of distribution of compounds in rabbits: In silico prediction and pharmacokinetic simulations for drug development.
    del Amo EM; Vellonen KS; Kidron H; Urtti A
    Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):215-26. PubMed ID: 25603198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physiological modelling of renal drug clearance.
    Janků I
    Eur J Clin Pharmacol; 1993; 44(6):513-9. PubMed ID: 8405004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Towards Further Verification of Physiologically-Based Kidney Models: Predictability of the Effects of Urine-Flow and Urine-pH on Renal Clearance.
    Matsuzaki T; Scotcher D; Darwich AS; Galetin A; Rostami-Hodjegan A
    J Pharmacol Exp Ther; 2019 Feb; 368(2):157-168. PubMed ID: 30413628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonlinear kinetics of the thiamine cation in humans: saturation of nonrenal clearance and tubular reabsorption.
    Weber W; Nitz M; Looby M
    J Pharmacokinet Biopharm; 1990 Dec; 18(6):501-23. PubMed ID: 2280348
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular characteristics of several drugs evaluated from solvent/water partition measurements: Solvation parameters and intramolecular hydrogen bond indicator.
    Ruiz R; Zamora WJ; Ràfols C; Bosch E
    Eur J Pharm Sci; 2022 Jan; 168():106066. PubMed ID: 34767947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of human renal clearance from preclinical species for a diverse set of drugs that exhibit both active secretion and net reabsorption.
    Paine SW; Ménochet K; Denton R; McGinnity DF; Riley RJ
    Drug Metab Dispos; 2011 Jun; 39(6):1008-13. PubMed ID: 21357702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enteric reabsorption processes and their impact on drug pharmacokinetics.
    Ibarra M; Trocóniz IF; Fagiolino P
    Sci Rep; 2021 Mar; 11(1):5794. PubMed ID: 33707635
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Kamiya Y; Handa K; Miura T; Yanagi M; Shigeta K; Hina S; Shimizu M; Kitajima M; Shono F; Funatsu K; Yamazaki H
    Chem Res Toxicol; 2021 Feb; 34(2):507-513. PubMed ID: 33433197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 4: prediction of plasma concentration-time profiles in human from in vivo preclinical data by using the Wajima approach.
    Vuppugalla R; Marathe P; He H; Jones RD; Yates JW; Jones HM; Gibson CR; Chien JY; Ring BJ; Adkison KK; Ku MS; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Poulin P
    J Pharm Sci; 2011 Oct; 100(10):4111-26. PubMed ID: 21480234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanistic models describing active renal reabsorption and secretion: a simulation-based study.
    Felmlee MA; Dave RA; Morris ME
    AAPS J; 2013 Jan; 15(1):278-87. PubMed ID: 23196805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utilization of estimated physicochemical properties as an integrated part of predicting hepatic clearance in the early drug-discovery stage: Impact of plasma and microsomal binding.
    Emoto C; Murayama N; Rostami-Hodjegan A; Yamazaki H
    Xenobiotica; 2009 Mar; 39(3):227-35. PubMed ID: 19280521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.